Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task
David Phenis, Sarah A. Vunck, Valentina Valentini, et al.
Psychopharmacology (2020) Vol. 237, Iss. 6, pp. 1723-1735
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Tryptophan Metabolism in Central Nervous System Diseases: Pathophysiology and Potential Therapeutic Strategies
Yinrou Huang, Mengke Zhao, Xuemei Chen, et al.
Aging and Disease (2022) Vol. 14, Iss. 3, pp. 858-858
Open Access | Times Cited: 63
Dysregulation of kynurenine pathway and potential dynamic changes of kynurenine in schizophrenia: A systematic review and meta-analysis
Bing Cao, Yan Chen, Zhongyu Ren, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 123, pp. 203-214
Closed Access | Times Cited: 56
Nicotine’s effect on cognition, a friend or foe?
Qian Wang, Weihong Du, Hao Wang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 124, pp. 110723-110723
Closed Access | Times Cited: 27
Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond
Maju Mathew Koola
Psychiatry Research (2020) Vol. 293, pp. 113409-113409
Closed Access | Times Cited: 65
Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators
Dina Manetti, Silvia Dei, Hugo R. Arias, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1270-1270
Open Access | Times Cited: 20
Addiction and the kynurenine pathway: A new dancing couple?
Nuria Morales‐Puerto, Pablo Giménez‐Gómez, Mercedes Pérez‐Hernández, et al.
Pharmacology & Therapeutics (2021) Vol. 223, pp. 107807-107807
Closed Access | Times Cited: 38
Relationships and Interactions between Ionotropic Glutamate Receptors and Nicotinic Receptors in the CNS
Trevor W. Stone
Neuroscience (2021) Vol. 468, pp. 321-365
Open Access | Times Cited: 38
Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
Mary E.W. Collier, Shaowei Zhang, Nigel S. Scrutton, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 6, pp. 1473-1481
Open Access | Times Cited: 29
Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow
Stephanie Hare, Bhim M. Adhikari, Mo Chen, et al.
Neuropsychopharmacology (2023) Vol. 48, Iss. 11, pp. 1594-1601
Closed Access | Times Cited: 12
MM165 - A Small Hybrid Molecule Modulates the Kynurenine Pathway and Attenuates Lipopolysaccharide-Induced Memory Deficits and Inflammation
Magdalena Kotańska, Michał Łanocha, Marek Bednarski, et al.
Neurochemical Research (2024) Vol. 49, Iss. 5, pp. 1200-1211
Open Access | Times Cited: 4
Nicotine: A Possible Neuroprotector in Brain Disorders
Karim A. Alkadhi, Samina Salim, Karem H. Alzoubi
Springer eBooks (2025), pp. 1-38
Closed Access
Cognitive Sequelae of COVID‐19: Mechanistic Insights and Therapeutic Approaches
Yuhao Chen, Jing‐Shiun Jan, Chih‐Hao Yang, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 3
Open Access
Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
Korrapati V. Sathyasaikumar, Verónica Pérez de la Cruz, Benjamín Pineda, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 315-315
Open Access | Times Cited: 18
Kynurenine‐3‐monooxygenase (KMO): From its biological functions to therapeutic effect in diseases progression
Yanmei Chen, Jiahui Zhang, Yueying Yang, et al.
Journal of Cellular Physiology (2022) Vol. 237, Iss. 12, pp. 4339-4355
Closed Access | Times Cited: 18
Tryptophan metabolism and ischemic stroke: An intricate balance
Chongjie Yao, Dong Xie, Yuchen Zhang, et al.
Neural Regeneration Research (2025) Vol. 21, Iss. 2, pp. 466-477
Open Access
Subchronic N-acetylcysteine Treatment Decreases Brain Kynurenic Acid Levels and Improves Cognitive Performance in Mice
Tonali Blanco Ayala, Daniela Ramírez Ortega, Paulina Ovalle Rodríguez, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 147-147
Open Access | Times Cited: 20
Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement
Maju Mathew Koola, Stephen W. Looney, Houlin Hong, et al.
Psychiatry Research (2020) Vol. 291, pp. 113285-113285
Closed Access | Times Cited: 19
Prefrontal α7nAChR Signaling Differentially Modulates Afferent Drive and Trace Fear Conditioning Behavior in Adolescent and Adult Rats
Anabel M. M. Miguelez Fernández, Hanna M. Molla, Daniel R. Thomases, et al.
Journal of Neuroscience (2021) Vol. 41, Iss. 9, pp. 1908-1916
Open Access | Times Cited: 16
Alpha7 nicotinic‐N‐methyl‐D‐aspartate hypothesis in the treatment of schizophrenia and beyond
Maju Mathew Koola
Human Psychopharmacology Clinical and Experimental (2020) Vol. 36, Iss. 1, pp. 1-16
Closed Access | Times Cited: 15
How do stupendous cannabinoids modulate memory processing via affecting neurotransmitter systems?
Salar Vaseghi, Mohammad Nasehi, Mohammad‐Reza Zarrindast
Neuroscience & Biobehavioral Reviews (2020) Vol. 120, pp. 173-221
Closed Access | Times Cited: 14
NLX-101, a cortical 5-HT1A receptor biased agonist, reverses scopolamine-induced deficit in the delayed non-matching to position model of cognition
Ronan Depoortère, Agnès L. Auclair, Adrian Newman‐Tancredi
Brain Research (2021) Vol. 1765, pp. 147493-147493
Closed Access | Times Cited: 11
Time of Day-Dependent Alterations in Hippocampal Kynurenic Acid, Glutamate, and GABA in Adult Rats Exposed to Elevated Kynurenic Acid During Neurodevelopment
Courtney J. Wright, Katherine M. Rentschler, Nathan T. J. Wagner, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 11
Ligand gated receptor interactions: A key to the power of neuronal networks
Robert A. Neff, Kumiko Kambara, Daniel Bertrand
Biochemical Pharmacology (2021) Vol. 190, pp. 114653-114653
Closed Access | Times Cited: 9
MM165 - a small hybrid molecule modulates the kynurenine pathway and attenuates lipopolysaccharide-induced memory deficits and inflammation
Magdalena Kotańska, Michał Łanocha, Marek Bednarski, et al.
Research Square (Research Square) (2024)
Open Access
Muscarinic cholinergic receptor antagonism impairs spatial memory retrieval and minimizes retrieval-induced alterations in matrix metalloproteinase-9
Mikel L. Olson, Bretton Badenoch, Megan Blatti, et al.
Behavioural Brain Research (2023) Vol. 448, pp. 114460-114460
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top